Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats von BOJUNGA, J, NOWAK, D, MITROU, P. S, HOELZER, D, ZEUZEM, S, CHOW, K. U

Volltext

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin’s lymphoma von Weidmann, E., Kim, S.-Z., Rost, A., Schuppert, H., Seipelt, G., Hoelzer, D., Mitrou, P. S.

Volltext

Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and impro... von Pönisch, W, Mitrou, P S, Merkle, K, Herold, M, Assmann, M, Wilhelm, G, Dachselt, K, Richter, P, Schirmer, V, Schulze, A, Subert, R, Harksel, B, Grobe, N, Stelzer, E, Schulze, M, Bittrich, A, Freund, M, Pasold, R, Friedrich, Th, Helbig, W, Niederwieser, D

Volltext

Diagnosis and actual therapy strategies in peripheral T-cell lymphomas: summary of an international meeting von Weidmann, E., Gramatzki, M., Wilhelm, M., Mitrou, P. S.

Volltext

Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma von Rummel, M.J, Chow, K.U, Karakas, T, Jäger, E, Mezger, J, von Grünhagen, U, Schalk, K.-P, Burkhard, O, Hansmann, M.-L, Ritzel, H, Bergmann, L, Hoelzer, D, Mitrou, P.S

Volltext

Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study von Rummel, M. J., Käfer, G., Pfreundschuh, M., Jäger, E., Reinhardt, U., Mitrou, P. S., Hoelzer, D., Bergmann, L.

Volltext

Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia von Bergmann, L., Fenchel, K., Jahn, B., Mitrou, P. S., Hoelzer, D.

Volltext

The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR von Brieger, J., Weidmann, E., Maurer, U., Hoelzer, D., Mitrou, P. S., Bergmann, L.

Volltext

Induction of apoptosis using 2', 2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism o... von CHOW, K. U, RIES, J, MITROU, P. S, WEIDMANN, E, POUREBRAHIM, F, NAPIERALSKI, S, STIELER, M, BOEHRER, S, RUMMEL, M. J, STEIN, J, HOELZER, D

Volltext

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse von Rummel, M. J., Chow, K. U., Jäger, E., Hossfeld, D. K., Bergmann, L., Peter, H.-D., Hansmann, M.-L., Meyer, A., Hoelzer, D., Mitrou, P. S.

Volltext

In lymphatic cells Par-4 sensitizes to apoptosis by down-regulating Bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation von BOEHRER, Simone, CHOW, Kai U, WEIDMANN, Eckhart, BESKE, Florian, KUKOC-ZIVOJNOV, Natasa, PUCCETTI, Elena, RUTHARDT, Martin, BAUM, Christine, RANGNEKAR, Vivek M, HOELZER, Dieter, MITROU, Paris S

Volltext

Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels von Hofmann, W K, Seipelt, G, Ottmann, O G, Kalina, U, Koschmieder, S, Brücher, J, Frickhofen, N, Klausmann, M, Mitrou, P S, Hoelzer, D

Volltext

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3... von Rummel, Mathias J, Prof Dr, Niederle, Norbert, Prof, Maschmeyer, Georg, Prof, Banat, G Andre, MD, von Grünhagen, Ulrich, MD, Losem, Christoph, MD, Kofahl-Krause, Dorothea, MD, Heil, Gerhard, Prof, Welslau, Manfred, MD, Balser, Christina, MD, Kaiser, Ulrich, Prof, Weidmann, Eckhart, Prof, Dürk, Heinz, MD, PhD, Ballo, Harald, MD, Stauch, Martina, MD, Roller, Fritz, MD, Barth, Juergen, Pharm, Hoelzer, Dieter, Prof, Hinke, Axel, PhD, Brugger, Wolfram, Prof

Volltext

Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501 von WEIDMANN, E, BRIEGER, J, KARAKAS, T, MAURER, U, PASCHEBERG, U, HOELZER, D, MITROU, P. S, BERGMANN, L

Volltext

In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine von Chow, KU, Boehrer, S, Geduldig, K, Krapohl, A, Hoelzer, D, Mitrou, PS, Weidmann, E

Volltext

Lactate dehydrogenase-release assay : a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemi... von WEIDMANN, E, BRIEGER, J, JAHN, B, HOELZER, D, BERGMANN, L, MITROU, P. S

Volltext

Peripheral T-Cell Lymphomas Respond Well to Vincristine, Adriamycin, Cyclophosphamide, Prednisone and Etoposide (VACPE) and Have a Similar Outcome as High-Grade B-Cell Lymphomas von Karakas, T., Bergmann, L., Stutte, H. J., Jäger, E., Knuth, A., Weidmann, E., Mitrou, P. S., Hoelzer, D.

Volltext

Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma : a multicenter phase II study von BERGMANN, L, KARAKAS, T, LAUTENSCHLÄGER, G, JÄGER, E, KNUTH, A, MITROU, P. S, HOELZER, D

Volltext

RAPID CYTOKINE RELEASE IN CANCER-PATIENTS TREATED WITH INTERLEUKIN-2 von WEIDMANN, E, BERGMANN, L, STOCK, J, KIRSTEN, R, MITROU, PS

Volltext

Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leuk... von GANSER, A, HEIL, G, HOELZER, D, KOLBE, K, MASCHMEYER, G, FISCHER, J. T, BERGMANN, L, MITROU, P. S, HEIT, W, HEIMPEL, H, HUBER, C

Volltext